BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38237348)

  • 1. The regulatory mechanisms of oncomiRs in cancer.
    Otmani K; Rouas R; Berehab M; Lewalle P
    Biomed Pharmacother; 2024 Feb; 171():116165. PubMed ID: 38237348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.
    Otmani K; Rouas R; Lewalle P
    Front Immunol; 2022; 13():913951. PubMed ID: 36189271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The duality of oncomiR addiction in the maintenance and treatment of cancer.
    Cheng CJ; Slack FJ
    Cancer J; 2012; 18(3):232-7. PubMed ID: 22647359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
    Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
    BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.
    Buechner J; Tømte E; Haug BH; Henriksen JR; Løkke C; Flægstad T; Einvik C
    Br J Cancer; 2011 Jul; 105(2):296-303. PubMed ID: 21654684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis.
    Tomasetti M; Amati M; Santarelli L; Neuzil J
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of microRNA in cancer and apoptosis.
    Lynam-Lennon N; Maher SG; Reynolds JV
    Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA biogenesis pathways in cancer.
    Lin S; Gregory RI
    Nat Rev Cancer; 2015 Jun; 15(6):321-33. PubMed ID: 25998712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential.
    Guz M; Jeleniewicz W; Cybulski M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.
    Otmani K; Lewalle P
    Front Oncol; 2021; 11():708765. PubMed ID: 34722255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
    Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
    Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in Oncogenesis and Tumor Suppression.
    Barbato S; Solaini G; Fabbri M
    Int Rev Cell Mol Biol; 2017; 333():229-268. PubMed ID: 28729026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR221/222 in cancer: their role in tumor progression and response to therapy.
    Garofalo M; Quintavalle C; Romano G; Croce CM; Condorelli G
    Curr Mol Med; 2012 Jan; 12(1):27-33. PubMed ID: 22082479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.
    Svoronos AA; Engelman DM; Slack FJ
    Cancer Res; 2016 Jul; 76(13):3666-70. PubMed ID: 27325641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-oncomir suppression of tumor phenotypes.
    Goga A; Benz C
    Mol Interv; 2007 Aug; 7(4):199-202, 180. PubMed ID: 17827440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours.
    Leichter AL; Sullivan MJ; Eccles MR; Chatterjee A
    Mol Cancer; 2017 Jan; 16(1):15. PubMed ID: 28103887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA and Metastasis.
    Ma L
    Adv Cancer Res; 2016; 132():165-207. PubMed ID: 27613133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncomirs - microRNAs with a role in cancer.
    Esquela-Kerscher A; Slack FJ
    Nat Rev Cancer; 2006 Apr; 6(4):259-69. PubMed ID: 16557279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.